NCT01462864

Brief Summary

Polycystic Ovary syndrome (PCOS) is a common hormonal imbalance affecting about 12% of women in the UK. The number of women with PCOS is rising. They suffer from a combination of symptoms including excess hair, irregular/absent periods, and infertility. About 70% of women with PCOS are obese or overweight, 10% develop type 2 diabetes (T2DM), and 30-40% have some degrees of abnormality in controlling (metabolising) blood sugar. Studies have shown that if women with PCOS make change to their lifestyle (diet and activity), they may reduce their risk of getting diabetes and heart disease in the future. This study aims to develop and test a programme that can be run in groups (structured education), to support women with PCOS make the lifestyle changes needed to improve their PCOS and prevent future associated health problems. Structured education programmes are suitable for use within the NHS and are already recommended for individuals with T2DM, but have not been tested as a method of treatment for PCOS which is a high risk condition for T2DM. The investigators aim to initially develop a specific education programme for women with PCOS using their expertise in their disease and defining their needs. The next step is to test this programme on 160 women with PCOS who will be selected from the investigators database or clinics. They will be divided randomly to two groups to receive either this programme or routine care. The investigators will give them an accelerometer (a very small portable device). This will measure their physical activity and counts their daily steps. The investigators aim is to increase their step count by at least 2000 steps per day after one year. The investigators believe that the group given the structured education will show some evidence of improvement in their glucose metabolism, and consequently decreased chance of developing diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2011

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 1, 2011

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

January 30, 2020

Status Verified

October 1, 2011

Enrollment Period

3.3 years

First QC Date

October 18, 2011

Last Update Submit

January 29, 2020

Conditions

Keywords

Polycystic Ovary SyndromeLifestyleStructured EducationWalking ActivityExerciseOverweightImpaired Glucose RegulationDiabetes Prevention

Outcome Measures

Primary Outcomes (1)

  • we aim for a 2000 steps increase in Number of steps per day

    It has been shown that 1 mmol/L drop in 2 hours glucose tolerance test following lifestyle intervention is significantly effective in diabetes prevention equal to 50% reduction in progression to T2DM. A previous similar intervention in people with IGR by our group in Leicester achieved a significant drop of 1.31 mmol/L (SD 2 mmol/L) in 2 hours glucose tolerance through an increase of 2000 steps per day in walking activity (SD 4000 steps/day).

    One year

Secondary Outcomes (8)

  • Physical Activity

    One year

  • Biochemical variables

    One year

  • Anthropometric and demographic

    One year

  • Health Related Quality of Life

    One Year

  • Exercise and Barrier Self Efficacy

    One Year

  • +3 more secondary outcomes

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Lifestyle education intervention

Behavioral: Structured Lifestyle Education

Control

NO INTERVENTION

The control group will receive an information leaflet which is generally distributed in our speciality clinic to patients with diagnosis of PCOS. The leaflet includes general information on PCOS, treatment options and advice on increasing physical activity.

Interventions

A 3-4 hours group education delivered in a patient group composed of 4-8 patients and delivered by two healthcare professionals.

Intervention

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Females aged between 18-50 years with the diagnosis of PCOS according to Rotterdam Criteria 2003 who are Overweight: (WHO 2010)
  • Body Mass Index ≥ 23 kg/m2 for Black and Minor Ethnicities
  • Body Mass Index ≥ 25 kg/m2 for White Europeans
  • If already on medical treatment for their PCOS, they should be on a stable regime for at least 6 months prior to the recruitment.

You may not qualify if:

  • Physical condition which limits full participation in the study
  • Active psychotic illness or a significant illness which, in the view of the investigators, would prevent full participation
  • Inability to communicate in verbal and written English
  • Steroid use
  • Diabetes
  • Pregnancy
  • Involvement in other research studies with similar nature

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals of Licester

Leicester, Leicestershire, LE1 5WW, United Kingdom

Location

MeSH Terms

Conditions

Polycystic Ovary SyndromeMotor ActivityOverweight

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesBehaviorOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Melanie J Davies, Prof (MD)

    University of Leicester

    PRINCIPAL INVESTIGATOR
  • Kamlesh Khunti, Prof (PhD)

    University of Leicester

    STUDY CHAIR
  • Hamidreza Mani, MD

    University of Leicester

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2011

First Posted

November 1, 2011

Study Start

September 1, 2011

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

January 30, 2020

Record last verified: 2011-10

Data Sharing

IPD Sharing
Will not share

Locations